This hypothesis could be evidenced by the fact that serum IgA levels against the Lipopolysaccharide (LPS) of enterobacteria were significantly higher in patients with CFS. This evidence concerns the gene CD79A and myalgic encephalomeyelitis/chronic fatigue syndrome.